胰腺神经内分泌肿瘤中18F-FDG、68Ga-FAPI与68Ga-DOTATATE PET/CT显像比较
Comparison of 18F-FDG, 68Ga-FAPI, and 68Ga-DOTATATE PET/CT in a Patient With Pancreatic Neuroendocrine Tumor.
PubMed 文献 · Clin Nucl Med · 2021-01-01
本文报道一例35岁女性胰腺神经内分泌肿瘤多发转移患者,分别行18F-FDG、68Ga-FAPI和68Ga-DOTATATE PET/CT显像。三种示踪剂均显示胰腺体部及肝脏多发高代谢灶,其中68Ga-FAPI的肿瘤/肝脏比值最高;但68Ga-DOTATATE PET/CT检出了FDG和FAPI均未发现的小转移淋巴结和骨转移灶。
要点
- 68Ga-FAPI PET/CT在胰腺神经内分泌肿瘤中肿瘤/肝脏比值最高。
- 68Ga-DOTATATE PET/CT可检出FDG和FAPI遗漏的小淋巴结及骨转移。
- 多种示踪剂PET/CT联合应用有助于全面评估胰腺神经内分泌肿瘤转移。
核心结论
- 三种示踪剂PET/CT均显示胰腺神经内分泌肿瘤多发转移灶,但68Ga-DOTATATE对小转移淋巴结和骨转移的检出优于FDG和FAPI。
研究设计与样本
- 本文为个案报道,描述一例35岁女性胰腺神经内分泌肿瘤多发转移患者的三种示踪剂PET/CT显像结果。
主要发现
- 18F-FDG、68Ga-FAPI和68Ga-DOTATATE PET/CT均显示胰腺体部和肝脏多发高代谢灶。
- 68Ga-FAPI PET/CT的肿瘤/肝脏比值最高。
- 68Ga-DOTATATE PET/CT检出了FDG和FAPI PET/CT均未发现的小转移淋巴结和骨转移灶。
临床怎么用
- 对胰腺神经内分泌肿瘤患者,可考虑联合应用68Ga-DOTATATE PET/CT以检出FDG和FAPI可能遗漏的小淋巴结及骨转移。
局限性
- 本文为单一病例报道,结论需更大样本研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
We present image findings of 18F-FDG, 68Ga-FAPI, and 68Ga-DOTATATE PET/CT in a 35-year-old woman with multiple metastases of pancreatic neuroendocrine tumor. The images of PET/CTs using 3 different tracers all showed multiple foci of increased activities in the liver and pancreas body, in which 68Ga-FAPI PET/CT displayed the highest tumor-to-liver ratios. However, 68Ga-DOTATATE PET/CT detected more small metastatic lymph node and bone metastases, which were missed by both FDG and FAPI PET/CT.
来源:Clin Nucl Med,查看原文。版权归原作者所有。
引用
- Cheng Z, Zou S, Cheng S, et al. Comparison of 18F-FDG, 68Ga-FAPI, and 68Ga-DOTATATE PET/CT in a Patient With Pancreatic Neuroendocrine Tumor. Clin Nucl Med. 2021. PMID: 34132674. doi:10.1097/RLU.0000000000003763
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。